Adiponectin and AdipoR1 regulate PGC-1α and mitochondria by Ca 2+ and AMPK/SIRT1

Nature

Volumn 464, Issue 7293, 2010, Pages 1313-1319

  Iwabu, Masato ^a,b   Yamauchi, Toshimasa ^a,b   Okada Iwabu, Miki ^a,b   Sato, Koji ^d   Nakagawa, Tatsuro ^e   Funata, Masaaki ^a   Yamaguchi, Mamiko ^a   Namiki, Shigeyuki ^a   Nakayama, Ryo ^a   Tabata, Mitsuhisa ^f   Ogata, Hitomi ^g   Kubota, Naoto ^a   Takamoto, Iseki ^a   Hayashi, Yukiko K ^h   Yamauchi, Naoko ^a   Waki, Hironori ^a   Fukayama, Masashi ^a   Nishino, Ichizo ^h   Tokuyama, Kumpei ^g   Ueki, Kohjiro ^a   Oike, Yuichi ^f   Ishii, Satoshi ^c   Hirose, Kenzo ^a   Shimizu, Takao ^c   Touhara, Kazushige ^d,e   Kadowaki, Takashi ^a   more..

^a GRADUATE SCHOOL OF MEDICINE   (Japan)

^b 22nd Century Medical and Research Center ^*  (Japan)

^c UNIVERSITY OF TOKYO   (Japan)

^d UNIVERSITY OF TOKYO   (Japan)

^e UNIVERSITY OF TOKYO   (Japan)

^f KUMAMOTO UNIVERSITY   (Japan)

^g UNIVERSITY OF TSUKUBA   (Japan)

^h NATIONAL INSTITUTE OF NEUROSCIENCE   (Japan)

Author keywords

[No Author keywords available]

Indexed keywords

ADENYLATE KINASE; ADIPONECTIN; ADIPONECTIN RECEPTOR 1; CALCIUM CALMODULIN DEPENDENT PROTEIN KINASE; CALCIUM ION; PEROXISOME PROLIFERATOR ACTIVATED RECEPTOR GAMMA COACTIVATOR 1ALPHA; SIRTUIN 1;

BIOCHEMISTRY; CALCIUM; CYTOLOGY; DIABETES; ENZYME ACTIVITY; HORMONE; MITOCHONDRION; PROTEIN;

ARTICLE; CALCIUM TRANSPORT; EXTRACELLULAR CALCIUM; INSULIN RESISTANCE; MITOCHONDRION; MUSCLE CELL; NONHUMAN; OXIDATIVE STRESS; PRIORITY JOURNAL;

ADIPONECTIN; AMP-ACTIVATED PROTEIN KINASES; ANIMALS; CALCIUM; CALCIUM SIGNALING; CALCIUM-CALMODULIN-DEPENDENT PROTEIN KINASE KINASE; CELL LINE; GLUCOSE; HOMEOSTASIS; INSULIN; INSULIN RESISTANCE; MICE; MITOCHONDRIA; MUSCLE CELLS; MUSCLE, SKELETAL; OOCYTES; OXIDATIVE STRESS; PHYSICAL CONDITIONING, ANIMAL; RECEPTORS, ADIPONECTIN; SIRTUIN 1; TRANS-ACTIVATORS; XENOPUS LAEVIS;

EID: 77951872309     PISSN: 00280836     EISSN: 14764687     Source Type: Journal    
DOI: 10.1038/nature08991     Document Type: Article

References (45)

1. Scherer, P. E., Williams, S., Fogliano, M., Baldini, G. & Lodish, H. F. A novel serum protein similar to C1q, produced exclusively in adipocytes. J. Biol. Chem. 270, 26746-26749 (1995).
2. Hu, E., Liang, P. & Spiegelman, B. M. AdipoQ is a novel adipose-specific gene dysregulated in obesity. J. Biol. Chem. 271, 10697-10703 (1996).
3. Maeda, K. et al. cDNA cloning and expression of a novel adipose specific collagenlike factor, apM1 (AdiPose Most abundant Gene transcript 1). Biochem. Biophys. Res. Commun. 221, 286-289 (1996).
4. Nakano, Y., Tobe, T., Choi-Miura, N.-H., Mazda, T. & Tomita, M. Isolation and characterization of GBP28, a novel gelatin-binding protein purified from human plasma. J. Biochem. 120, 803-812 (1996).
5. Hotta, K. et al. Plasma concentrations of a novel, adipose-specific protein, adiponectin, in type 2 diabetic patients. Arterioscler. Thromb. Vasc. Biol. 20, 1595-1599 (2000).
6. Fruebis, J. et al. Proteolytic cleavage product of 30-kDa adipocyte complement-related protein increases fatty acid oxidation in muscle and causes weight loss in mice. Proc. Natl Acad. Sci. USA 98, 2005-2010 (2001).
7. Yamauchi, T. et al. The fat-derived hormone adiponectin reverses insulin resistance associated with both lipoatrophy and obesity. Nature Med. 7, 941-946 (2001).
8. Berg, A. H., Combs, T. P., Du, X., Brownlee, M. & Scherer, P. E. The adipocyte-secreted protein Acrp30 enhances hepatic insulin action. Nature Med. 7, 947-953 (2001).
9. Kubota, N. et al. Disruption of adiponectin causes insulin resistance and neointimal formation. J. Biol. Chem. 277, 25863-25866 (2002).
10. Maeda, N. et al. Diet-induced insulin resistance in mice lacking adiponectin/ACRP30. Nature Med. 8, 731-737 (2002).
11. Yamauchi, T. et al. Adiponectin stimulates glucose utilization and fatty-acid oxidation by activating AMP-activated protein kinase. Nature Med. 8, 1288-1295 (2002).
12. Tomas, E. et al. Enhanced muscle fat oxidation and glucose transport by ACRP30 globular domain: acetyl-CoA carboxylase inhibition and AMP-activated protein kinase activation. Proc. Natl Acad. Sci. USA 99, 16309-16313 (2002).
13. Kahn, B. B., Alquier, T., Carling, D. & Hardie, D. G. AMP-activated protein kinase: ancient energy gauge provides clues to modern understanding of metabolism. Cell Metab. 1, 15-25 (2005).
14. Kersten, S., Desvergne, B. & Wahli, W. Roles of PPARs in health and disease. Nature 405, 421-424 (2000).
15. Yamauchi, T. et al. Globular adiponectin protected ob/ob mice from diabetes and apoE deficient mice from atherosclerosis. J. Biol. Chem. 278, 2461-2468 (2003).
16. Yamauchi, T. et al. Cloning of adiponectin receptors that mediate antidiabetic metabolic effects. Nature 423, 762-769 (2003).
17. Wess, J. G-protein-coupled receptors: molecular mechanisms involved in receptor activation and selectivity of G-protein recognition. FASEB J. 11, 346-354 (1997).
18. Yokomizo, T., Izumi, T., Chang, K., Takuwa, Y. & Shimizu, T. A. G-protein-coupled receptor for leukotriene B4 that mediates chemotaxis. Nature 387, 620-624 (1997).
19. Scheer, A., Fanelli, F., Costa, T., De Benedetti, P. G. & Cotecchia, S. Constitutively active mutants of the a1B-adrenergic receptor: role of highly conserved polar amino acids in receptor activation. EMBO J. 15, 3566-3578 (1996).
20. Yamauchi, T. et al. Targeted disruption of AdipoR1 and AdipoR2 causes abrogation of adiponectin binding and metabolic actions. Nature Med. 13, 332-339 (2007).
21. Petersen, K. F. et al. Impaired mitochondrial activity in the insulin-resistant offspring of patients with type 2 diabetes. N. Engl. J. Med. 350, 664-671 (2004).
22. Wu, Z. et al. Mechanisms controlling mitochondrial biogenesis and respiration through the thermogenic coactivator PGC-1. Cell 98, 115-124 (1999).
23. Mootha, V. K. et al. Erra and Gabpa/b specify PGC-1a-dependent oxidative phosphorylation gene expression that is altered in diabetic muscle. Proc. Natl Acad. Sci. USA 101, 6570-6575 (2004).
24. Berchtold, M. W. et al. Calcium ion in skeletal muscle: its crucial role for muscle function, plasticity, and disease. Physiol. Rev. 80, 1215-1265 (2000).
25. Wu, H. et al. MEF2 responds to multiple calcium-regulated signals in the control of skeletal muscle fiber type. EMBO J. 19, 1963-1973 (2000).
26. Hotamisligil, G. S. Inflammation and metabolic disorders. Nature 444, 860-867 (2006).
27. Um, S. H. et al. Absence of S6K1 protects against age-and diet-induced obesity while enhancing insulin sensitivity. Nature 431, 200-205 (2004).
28. Hawley, S. A. et al. Characterization of the AMP-activated protein kinase kinase from rat liver and identification of threonine 172 as the major site at which it phosphorylates AMP-activated protein kinase. J. Biol. Chem. 271, 27879-27887 (1996).
29. Hawley, S. A. et al. Calmodulin-dependent protein kinase kinase-b is an alternative upstream kinase for AMP-activated protein kinase. Cell Metab. 2, 9-19 (2005).
30. 21/calmodulin-dependent protein kinase kinase-b acts upstream of AMP-activated protein kinase in mammalian cells. Cell Metab. 2, 21-33 (2005).
31. Jäger, S., Handschin, C., St-Pierre, J. & Spiegelman, B. M. AMP-activated protein kinase (AMPK) action in skeletal muscle via direct phosphorylation of PGC-1a. Proc. Natl Acad. Sci. USA 104, 12017-12022 (2007).
32. Rodgers, J. T. et al. Nutrient control of glucose homeostasis through a complex of PGC-1a and SIRT1. Nature 434, 113-118 (2005).
33. Guarente, L. Sirtuins as potential targets for metabolic syndrome. Nature 444, 868-874 (2006).
34. 21/calmodulin-dependent protein kinase kinase. J. Biol. Chem. 277, 15813-15818 (2002).
35. i levels in rat skeletal muscle in vivo. Am. J. Physiol. Heart Circ. Physiol. 275, H1652-H1662 (1998).
36. 21 from sarcoplasmic reticulum to mitochondria in skeletal muscle. J. Biol. Chem. 281, 1547-1554 (2006).
37. 21/calmodulin-dependent protein kinase kinase beta. J. Biol. Chem. 273, 31880-31889 (1998).
38. Soderling, T. R. The Ca-calmodulin-dependent protein kinase cascade. Trends Biochem. Sci. 24, 232-236 (1999).
39. Handschin, C. & Spiegelman, B. M. The role of exercise and PGC1a in inflammation and chronic disease. Nature 454, 463-469 (2008).
40. Handschin, C. et al. Skeletal muscle fiber-type switching, exercise intolerance, and myopathy in PGC-1a muscle-specific knock-out animals. J. Biol. Chem. 282, 30014-30021 (2007).
41. Mootha, V. K. et al. PGC-1a-responsive genes involved in oxidative phosphorylation are coordinately downregulated in human diabetes. Nature Genet. 34, 267-273 (2003).
42. Patti, M. E. et al. Coordinated reduction of genes of oxidative metabolism in humans with insulin resistance and diabetes: Potential role of PGC1 and NRF1. Proc. Natl Acad. Sci. USA 100, 8466-8471 (2003).
43. Wang, C. et al. Adiponectin sensitizes insulin signaling by reducing p70 S6 kinase-mediated serine phosphorylation of IRS-1. J. Biol. Chem. 282, 7991-7996 (2007).
44. Houstis, N., Rosen, E. D. & Lander, E. S. Reactive oxygen species have a causal role in multiple forms of insulin resistance. Nature 440, 944-948 (2006).
45. St-Pierre, J. et al. Suppression of reactive oxygen species and neurodegeneration by the PGC-1transcriptional coactivators. Cell 127, 397-408 (2006).